Back
CollPlant Biotechnologies Ltd. 10K Form
Sell
26
CLGN
CollPlant Biotechnologies Ltd.
Last Price:
$1.49
Seasonality Move:
10.82%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLGN News And Ratings
See the #1 stock for the next 7 days that we like better than CLGN
CLGN Financial Statistics
Sales & Book Value
| Annual Sales: | $515K |
|---|---|
| Cash Flow: | $-3.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.73 |
| Price / Book: | 2.05 |
Profitability
| EPS (TTM): | -1.02190 |
|---|---|
| Net Income (TTM): | $-12.2M |
| Gross Margin: | $-2.1M |
| Return on Equity: | -94.13% |
| Return on Assets: | -67.64% |
CollPlant Biotechnologies Ltd. Earnings Forecast
Key CollPlant Biotechnologies Ltd. Financial Ratios
-
The Gross Profit Margin over the past 11 years for CLGN is -417.09%.
-
The Selling, General & Administrative Expenses for CLGN have been equal to 1,092.43% of Gross Profit Margin.
-
The Research & Development expenses have been 2,041.75% of Revenue.
-
The Net Earning history of CLGN is -3,225.05% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 5 years.
CollPlant Biotechnologies Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLGN |
| CUSIP: | 19516Q |
| Website: | collplant.com |
Debt
| Debt-to-Equity Ratio: | 0.32 |
|---|---|
| Current Ratio: | 3.66 |
| Quick Ratio: | 3.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLGN Technical Analysis vs Fundamental Analysis
Sell
26
CollPlant Biotechnologies Ltd. (CLGN)
is a Sell
Is CollPlant Biotechnologies Ltd. a Buy or a Sell?
-
CollPlant Biotechnologies Ltd. stock is rated a SellThe current CollPlant Biotechnologies Ltd. [CLGN] share price is $1.47. The Score for CLGN is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.